Valenta Pharm is a Russian innovative pharmaceutical company established in 1997 and focused on development and production of new original medicines.
Valenta Pharm is engaged in development, production, and market launch of prescription and OTC medicines for such therapeutic areas as immunology, virology and antibacterial therapy, psychoneurology, gastroenterology, urology, etc.
The company's medicines portfolio comprises well-known brands as Ingaverin®, Grammidin®, Trimedat®, Teraligen®, Phenazepamum®, Pantocalcin®, Aminazine®, etc.
Valenta Pharm are looking for innovative solutions in pharmaceutical developments in dermatology, with a particular interest in mycosis of skin and nails, psoriasis and dermatitis and preferably that are in phase 2 of clinical research, or are market-ready.
A successful collaboration could mean, for individuals, becoming part of the wider Valenta Pharm group, while for organisations, forming a partnership/joint venture to co-develop and co-launch the idea to market.
This is a global challenge and Valenta Pharm are willing to collaborate with both individuals/freelancers and other industry participants/universities etc. and solutions can be at any stage of development, from concept to market-ready. However, solutions that are in phase 2 of clinical research, or are market-ready are preferable.
If you have or are developing solutions, or if you have expertise in this area and would like to get in front of Valenta Pharm, please click "Apply" to submit your solution/expertise to the Network. Applications close on the 2nd of October 2018.